Kangji Medical Holdings Ltd
HKEX:9997
Net Margin
Kangji Medical Holdings Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
K
|
Kangji Medical Holdings Ltd
HKEX:9997
|
10.2B HKD |
58%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
36.4B CHF |
11%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
6.5T JPY |
23%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
140.1B DKK |
16%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
15B USD |
10%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.9B CHF |
12%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.9B GBP |
8%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
44.1B CNY |
40%
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.1B USD |
-8%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5B USD |
17%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.9B USD |
9%
|
Kangji Medical Holdings Ltd
Glance View
Kangji Medical Holdings Ltd., nestled in the bustling backdrop of China's thriving medical device industry, has carved a niche for itself in the realm of minimally invasive surgery (MIS). Since its inception, the company has focused on designing and manufacturing a range of surgical tools and devices that cater specifically to MIS procedures. These procedures, which include general surgery, gynecology, and urology, are gaining popularity due to their reduced recovery times and lower risk factors compared to traditional surgery. Kangji Medical leverages its robust R&D capabilities and intimate understanding of physicians' needs to deliver high-quality, ergonomic instruments that enhance operational precision and patient outcomes. The lifeblood of Kangji Medical lies in its strategic manufacturing and marketing prowess, enabling it to maintain a solid foothold in the competitive landscape. By keeping its production chain streamlined and efficient, the company achieves significant cost advantages, which in turn translates to competitive pricing. These savings are reinvested in expanding its product portfolio and enhancing technological innovations, thus ensuring a constant edge over its peers. Moreover, Kangji's astute distribution networks and partnerships with leading hospitals enable it to secure a steady demand flow for its products. This strategy has not only facilitated steady revenue growth but also ensured Kangji's reputation as a reliable contributor to the advancing field of minimally invasive surgical procedures.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Kangji Medical Holdings Ltd's most recent financial statements, the company has Net Margin of 57.7%.
You don't have any saved screeners yet